Matthew Riesbeck, DO
Advanced Heart Failure and Transplant Cardiology · Asheville, NCNPI 1154701696
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.4% of the total across 322 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by Abbott at 46.1% of the total. 2025 is the largest year on record at $3,575, 7.7 times the $462 reported in 2019. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in NC, where the typical reported total is $18,861.
Across 322 payments — averaging $39.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Actelion Pharmaceuticals US, Inc.$927
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$644
- Impulse Dynamics (USA) Inc.$578
- United Therapeutics Corporation$452
- Boehringer Ingelheim$436
- plus $4K from 27 others
What the payments were for
- Food & beverage$12,03595%
- Education$5875%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 108 | $5,825 |
| Actelion Pharmaceuticals US, Inc. | 27 | $927 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $644 |
| Impulse Dynamics (USA) Inc. | 13 | $578 |
| United Therapeutics Corporation | 18 | $452 |
| Boehringer Ingelheim | 18 | $436 |
| AstraZeneca | 21 | $393 |
| Merck | 13 | $331 |
| Biotronik Inc. | 8 | $317 |
| Bard Peripheral Vascular, Inc. | 2 | $290 |
| Bayer | 14 | $289 |
| Cvrx, Inc. | 4 | $230 |
| Boston Scientific | 3 | $224 |
| Pfizer | 10 | $212 |
| E.r. Squibb & Sons, L.L.C. | 12 | $206 |
| Novartis | 8 | $163 |
| Bridgebio Pharma, Inc. | 5 | $159 |
| ZOLL Respicardia, Inc. | 1 | $142 |
| Abiomed | 1 | $129 |
| Siemens Medical Solutions USA, Inc. | 1 | $120 |
| Johnson & Johnson | 6 | $97 |
| Philips North America LLC | 2 | $90 |
| Amgen | 4 | $72 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $51 |
| Cardiva Medical, Inc. | 2 | $48 |
| Sanofi-aventis U.S. LLC | 2 | $46 |
| Alnylam Pharmaceuticals Inc. | 1 | $31 |
| Lexicon Pharmaceuticals, Inc. | 1 | $27 |
| Novo Nordisk | 1 | $20 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $19 |
| Shockwave Medical, Inc | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Chiesi USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CARDIOMEMS$1,488
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$751
- OPTIMIZER$654
- QUADRA ASSURA$249
- Merlin Connectivity and Remote$148
- Mitra Clip system$146
- remede System$142
- Durata Defibrillation ICD Lead$142
- Rotarex$140
- Impella$129
- UPTRAVI$129
- OPSUMIT$129
- JARDIANCE$125
- Barostim Neo System$124
- Confirm Rx$122
- Artis icono$120
- HeartMate Touch$116
- NAVITOR$115
- Watchman$100
How this compares
$12,622 in reported general payments places this provider in the 40th percentile of 31 advanced heart failure and transplant cardiology providers in North Carolina.
See all advanced heart failure and transplant cardiology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UptraviSelexipag | 36 | $612,628 |
| OpsumitMacitentan | 32 | $405,857 |
| Tyvaso DpiTreprostinil | 17 | $402,887 |
| AdempasRiociguat | 15 | $185,481 |
| EntrestoSacubitril/Valsartan | 118 | $122,322 |
| JardianceEmpagliflozin | 107 | $114,252 |
| FarxigaDapagliflozin Propanediol | 82 | $88,666 |
| EliquisApixaban | 77 | $62,040 |
| XareltoRivaroxaban | 24 | $26,784 |
| Sildenafil Citrate | 32 | $10,500 |
| Torsemide | 97 | $1,524 |
| Metoprolol Succinate | 99 | $1,380 |
| Spironolactone | 143 | $1,200 |
| Bumetanide | 51 | $1,183 |
| Losartan Potassium | 77 | $716 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Actelion Pharmaceuticals US, Inc.Uptravi, Opsumit | $927 | $1,018,48568 claims |
| BayerAdempas | $289 | $185,48115 claims |
| NovartisEntresto | $163 | $122,322118 claims |
| Boehringer IngelheimJardiance | $436 | $114,252107 claims |
| AstraZenecaFarxiga | $393 | $88,66682 claims |
| PfizerEliquis | $212 | $62,04077 claims |
| Johnson & JohnsonXarelto | $97 | $26,78424 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 31 advanced heart failure and transplant cardiology providers in North Carolina.
Other advanced heart failure and transplant cardiology in Asheville
- Vinay ThohanAsheville$164K
- Benjamin TrichonAsheville$37K
- Daniel BensimhonGreensboro$2.1M
- Stephen GreeneDurham$582K
- John RommelWilmington$263K
- Stephen ZouzoulasConcord$244K
- Hassan AlhosainiWinston Salem$195K
- Kishan ParikhRaleigh$158K
- Emil MissovGreenville$71K
- David IshizawarRaleigh$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.